Plain-English translation of NCT07939139 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial evaluates an artificial intelligence assistant designed to help multidisciplinary tumor boards—teams of cancer specialists who plan treatment together. The AI system reviews your medical records, diagnosis, test results, and current medical guidelines to draft a recommended treatment plan. The study compares what the AI suggests with what the actual doctor team decides, to see how often they agree and whether the AI's suggestions are helpful.
Cancer treatment planning is complex and requires expertise from many specialists working together. This trial exists to test whether an AI assistant can help these teams organize information and generate well-reasoned treatment recommendations more consistently, potentially improving the planning process for future patients.
You likely qualify if…
You likely don't qualify if…
Your participation is entirely passive—you do not need to do anything or visit the hospital for the study. The AI system will review your existing medical records and documents that are already part of your cancer care before your treatment planning meeting. The doctors will make their treatment decisions as usual, and researchers will later compare the AI's draft recommendations with the actual medical team's decision to evaluate how well they match. No additional procedures, tests, or contact with you will occur for this study.
AI-generated summary from trial data · Nov 17, 2026 · Not medical advice
Germany